Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial

BACKGROUND: Nausea and vomiting of pregnancy (NVP) is the most common medical condition in pregnancy, affecting up to 80% of expecting mothers. In April 2013 the FDA approved the delayed release combination of doxylamine succinate and -pyridoxine hydrochloride (Diclegis®) for NVP, following a phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Koren, Gideon, Clark, Shannon, Hankins, Gary D V, Caritis, Steve N, Umans, Jason G, Miodovnik, Menachem, Mattison, Donald R, Matok, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391332/
https://www.ncbi.nlm.nih.gov/pubmed/25884778
http://dx.doi.org/10.1186/s12884-015-0488-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391332/
https://www.ncbi.nlm.nih.gov/pubmed/25884778
http://dx.doi.org/10.1186/s12884-015-0488-1

Ejemplares similares